These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7043711)

  • 21. Goldsalts, levamisole and D-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis--a long-term follow-up study.
    Veys EM; Mielants H; Verbruggen G
    Clin Exp Rheumatol; 1987; 5(2):111-6. PubMed ID: 3608266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Clinical, biochemical, radiological and scintigraphic studies.
    Halberg P; Bentzon MW; Crohn O; Gad I; Halskov O; Heyn J; Ingemann M; Junker P; Lorenzen I; Møller I
    Dan Med Bull; 1984 Oct; 31(5):403-9. PubMed ID: 6391849
    [No Abstract]   [Full Text] [Related]  

  • 23. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of rheumatoid arthritis with levamisole. A controlled trial.
    Runge LA; Pinals RS; Lourie SH; Tomar RH
    Arthritis Rheum; 1977; 20(8):1445-8. PubMed ID: 336052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of rheumatoid arthritis with levamisole].
    Schuermans Y; Cree J; Symoens J; Verhaegen H
    Rev Rhum Mal Osteoartic; 1976 Jun; 43(6):437-40. PubMed ID: 781791
    [No Abstract]   [Full Text] [Related]  

  • 26. The place of levamisole in the armamentarium for rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1978; 4():149-52. PubMed ID: 282445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levamisole: possibilities of immunomodulation in the basic treatment of rheumatoid arthritis. Clinical and immunological observations in a one-year decaris treatment of rheumatoid arthritis patients.
    Hodinka L; Merétey K; Zahumenszky Z; Bozsóky S
    Ther Hung; 1981; 29(4):162-9. PubMed ID: 7188142
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].
    Lemmel EM; Bach GL; Bolten W; Brackertz D; Fahmy Z; Mattern H; Stroehmann I; Wittenborg A
    Dtsch Med Wochenschr; 1988 Feb; 113(5):172-6. PubMed ID: 3276492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the order of second-line treatment in rheumatoid arthritis matter?
    Steven MM; Hunter JA; Murdoch RM; Capell HA
    Br Med J (Clin Res Ed); 1982 Jan; 284(6309):79-81. PubMed ID: 6797663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical response to therapy with thymopoietin pentapeptide (TP-5) in rheumatoid arthritis.
    Veys EM; Huskisson EC; Rosenthal M; Vischer TL; Mielants H; Thrower PA; Scott J; Ott H; Scheijgrond H; Symoens J
    Ann Rheum Dis; 1982 Oct; 41(5):441-3. PubMed ID: 6751241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chlorbutin, azathioprine, D-penicillamine and levamisole (decaris) in the treatment of patients with rheumatoid arthritis. IV. Comparative evaluation of their effects on systemic (extra-articular) manifestations of the disease].
    Krel' AA; Kanevskaia MZ; Chichasova NV; Khamishon LZ; Nemchenov EN
    Ter Arkh; 1985; 57(8):44-52. PubMed ID: 3906995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)].
    Rondier J; Cayla J; Tron F; Roger M; Bach JF
    Nouv Presse Med; 1978 Oct; 7(34):3023-7, 3029-30. PubMed ID: 364409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis.
    Balogh Z; El-Ghobarey AF; Fell GS; Brown DH; Dunlop J; Dick WC
    Ann Rheum Dis; 1980 Aug; 39(4):329-32. PubMed ID: 7436558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of rheumatoid arthritis by levamisole. First results].
    Sany J; Morlock G; Clot J; Serre H
    Rev Rhum Mal Osteoartic; 1977 Mar; 44(3):143-53. PubMed ID: 322247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymopoietin pentapeptide treatment of sarcoidosis.
    Thivolet J; Faure M
    J Am Acad Dermatol; 1983 Nov; 9(5):773-4. PubMed ID: 6643779
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review.
    Franchimont P; Heynen G; Hauwaert CH
    J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies.
    Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G
    J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [D-penicillamine (Artamin) as basic therapeutic agent in the treatment of chronic rheumatoid arthritis].
    Tausch G; Bröll H; Eberl R
    Wien Klin Wochenschr; 1973 Jan; 85(4):59-63. PubMed ID: 4567434
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.